Global COVID-19 Rapid Diagnostic Test Kit Market Growth 2025-2031

The global COVID-19 Rapid Diagnostic Test Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The COVID-19 Rapid Diagnostic Test Kit is divided into COVID-19 Rapid Diagnostic Test Kit and COVID-19 Antigen Rapid Test Kit according to the detection components.

The COVID-19 Rapid Diagnostic Test Kit market has been driven by several factors:

Urgent Need for Rapid Testing: The rapid spread of the COVID-19 virus required fast and accurate diagnostic tools to identify infected individuals quickly. Rapid diagnostic test kits provide results within a short period, enabling timely isolation and treatment.

Mass Testing and Screening Efforts: Many countries and regions initiated mass testing and screening campaigns to identify and isolate infected individuals. Rapid diagnostic test kits were crucial in facilitating these large-scale testing efforts.

Ease of Use and Accessibility: Rapid test kits are often designed to be user-friendly and can be administered without the need for specialized equipment or trained personnel. This accessibility made them valuable in various settings, including remote or resource-limited areas.

Quick Results: The ability to provide results within minutes to hours is a significant advantage of rapid test kits. This speed aids in reducing the time individuals spend waiting for results and allows for faster decision-making.

Surge in Demand: The global demand for COVID-19 testing, especially during outbreaks or waves of infections, significantly increased the demand for rapid diagnostic test kits.

Supplementing PCR Testing: While PCR tests are considered the gold standard for COVID-19 diagnosis, they can be time-consuming and require laboratory infrastructure. Rapid test kits provide a complementary approach, especially for initial screenings and quick results.

Travel and Border Control: Rapid diagnostic test kits have been used in many countries as part of travel and border control measures. They allow for on-the-spot testing of travelers and can contribute to reducing the spread of the virus across borders.

Employment and Public Spaces: Many workplaces, schools, and public spaces require regular testing to ensure safety. Rapid diagnostic test kits have been instrumental in monitoring and managing COVID-19 in these environments.



LP Information, Inc. (LPI) ' newest research report, the “COVID-19 Rapid Diagnostic Test Kit Industry Forecast” looks at past sales and reviews total world COVID-19 Rapid Diagnostic Test Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected COVID-19 Rapid Diagnostic Test Kit sales for 2025 through 2031. With COVID-19 Rapid Diagnostic Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 Rapid Diagnostic Test Kit industry.

This Insight Report provides a comprehensive analysis of the global COVID-19 Rapid Diagnostic Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COVID-19 Rapid Diagnostic Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COVID-19 Rapid Diagnostic Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 Rapid Diagnostic Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 Rapid Diagnostic Test Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Rapid Diagnostic Test Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Antibody Rapid Test Kit
Antigen Rapid Test Kit

Segmentation by Application:
Hospital
Company
School
Home
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva

Key Questions Addressed in this Report

What is the 10-year outlook for the global COVID-19 Rapid Diagnostic Test Kit market?

What factors are driving COVID-19 Rapid Diagnostic Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do COVID-19 Rapid Diagnostic Test Kit market opportunities vary by end market size?

How does COVID-19 Rapid Diagnostic Test Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.